Total medical devices industry venture financing deals in June 2019 worth $661.16m were announced globally, according to GlobalData’s deals database.
Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked a decrease of 49.4% over the previous month and a drop of 15.9% when compared with the last 12-month average, which stood at $786.21m.
Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $515.42m. At the country level, the US topped the list in terms of deal value at $515.05m.
In terms of volumes, North America emerged as the top region for medical devices industry venture financing deals globally, followed by Europe and then Asia-Pacific.
The top country in terms of venture financing deals activity in June 2019 was the US with 50 deals, followed by China with nine and Canada with eight.
In 2019, as of the end of June 2019, medical devices venture financing deals worth $5.03bn were announced globally, marking a decrease of 2.9% year on year.
Medical devices industry venture financing deals in June 2019: Top deals
The top five medical devices industry venture financing deals accounted for 44.5% of the overall value during June 2019.
The combined value of the top five medical devices industry venture financing deals stood at $294.34m, against the overall value of $661.16m recorded for the month. The top announced medical devices industry venture financing deal tracked by GlobalData in June 2019 was 8VC, Advent Venture Partners, Deerfield ManagementLP, GE Ventures, Opaleye Management, Orbimed Advisors, Pura Vida Investments and Xeraya Capital Sdn’s $100m venture financing of Acutus Medical.
In second place was the $73m venture financing of Omada Health by Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners XII, Providence Ventures, Sanofi Ventures, USVP ManagementLlc and Wellington ManagementLLP and in third place was BPI France, Dassault Systemes, IDInvest Partners and LBO France’s $72.94m venture financing of BioSerenity.
The $26.4m venture financing of Purigen Biosystems by 5AM Venture Management, Agilent Technologies, Cota Capital Management and Roche Venture Fund and 6 Dimensions Capital, Applied Ventures, ARCH Venture Partners, Northpond Ventures and Yonghua Capital’s venture financing of Ultivue for $22m held fourth and fifth positions, respectively.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.